Abstract
The authors describe the demographics, clinical presentation, investigation, treatment, and outcomes of pediatric patients with Guillain-Barré syndrome. They identified 35 pediatric patients with Guillain-Barré syndrome presenting to a tertiary academic center over a 20-year period. The most common presenting symptoms were paresthesias (54%), weakness (49%), and myalgias (49%). Sensation was affected in 54% of patients, and hyporeflexia or areflexia was present in 94% of patients. Cranial nerve dysfunction (46%) and autonomic involvement (eg, changes in blood pressure, pulse, bowel/bladder control, or priapism; 46%) were also common. Autonomic dysfunction, cranial nerve involvement, and albuminocytological dissociation were significantly associated with a decreased time to nadir, the point when symptoms peaked (P =.015,.007, and.005, respectively). Although not statistically significant, treatment with plasmapheresis had a better success rate than intravenous immunoglobulin. The authors' results will help to further delineate the clinical picture of Guillain-Barré syndrome in children and refine treatment strategies.
Original language | English (US) |
---|---|
Pages (from-to) | 1504-1510 |
Number of pages | 7 |
Journal | Journal of child neurology |
Volume | 25 |
Issue number | 12 |
DOIs | |
State | Published - Dec 2010 |
Externally published | Yes |
Keywords
- Guillain-Barré syndrome
- demyelinating disease
- pediatrics
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Clinical Neurology